Bladder cancer chemotherapy trial generates more questions than it answers.
Newman
L
L
D000970:Antineoplastic Agents / Q000627:therapeutic use / Q000633:toxicity; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000633:toxicity; D002945:Cisplatin / Q000008:administration & dosage / Q000633:toxicity; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage / Q000633:toxicity; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000633:toxicity; D012074:Remission Induction; D013997:Time Factors; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality; D014747:Vinblastine / Q000008:administration & dosage / Q000633:toxicity
D000970:Antineoplastic Agents; D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate